Dr. Nader N. Hanna is a surgical oncologist who specializes in colorectal surgery and other abdominal surgeries at the University of Maryland Medical System. He is a valued team member within the Mesothelioma and Thoracic Oncology Treatment and Research Center, providing surgical expertise in the care of patients diagnosed with malignant peritoneal mesothelioma, a form of the rare asbestos-related cancer that manifests in the lining of the abdomen. Dr. Hanna is skilled in the complex procedure known as cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, in which a heated chemotherapy solution is administered to a surgical site after all visible cancerous material has been removed.
In addition to caring for patients with malignant mesothelioma, Dr. Hanna is an expert in advanced and complex surgical oncology procedures including esophagectomy, gastrectomy, major liver resection, Whipple procedure, and pelvic exenteration for the treatment of advanced/recurrent and metastatic gastrointestinal cancers.
Education and Career
Board-certified in General Surgery with a specialty certification in Surgical Oncology, Dr. Hanna began his medical education at the Ain Shams University Faculty of Medicine in Egypt. He completed a rotating internship there and an internship in Medicine and Surgery at Deaconess Waltham Hospital in Massachusetts. Following his internship he was a resident in Surgery and Chief Surgical Resident at St. Elizabeth Medical Center, Tufts University School of Medicine in Boston, then completed a fellowship in Surgical Oncology and was a Postdoctoral Research Fellow in the Division of the Biological Sciences, Department of Radiation & Cellular Oncology, at the University of Chicago Pritzker School of Medicine.
Following the completion of his fellowships, Dr. Hanna spent several years as a faculty member and member of the Department of Surgery at the University of Kentucky School of Medicine in Lexington and the UK Markey Cancer Center. Today he is a Professor of Surgery at the University of Maryland School of Medicine and the Director of Clinical Operations of the Division of General and Oncologic Surgery at the University of Maryland Medical Center, as well as the Director of the Cancer Institute at the University of Maryland St. Joseph Medical Center.
Dr. Hanna’s research interests include outcomes research and clinical trials as well as gene therapy for pancreatic cancer and radio-sensitization for GI malignancies. His work has been published in highly respected journals including Nature, Nature Medicine, Cancer Research, Human Gene Therapy, Journal of Clinical Oncology, Oncologist, Colorectal Disease, Annals of Surgical Oncology, Annals of Surgery, andJournal of American College of Surgeons.
Among his published works is a study titled “Treatment Factors Associated With Long-Term Survival Following Cytoreductive Surgery and Regional Chemotherapy for Patients with Malignant Peritoneal Mesothelioma” published in the journal Surgery.
Society of Surgical Oncology
American College of Surgeons
American Society of Clinical Oncology
Association for Academic Surgery
Leadership Society of the American College of Surgeons
International College of Surgeons
Society of University Surgeons
American Academy on Communications in Healthcare